NO310305B1 - Matrise med adherent bundede celler, samt fremgangsmåte ved fremstilling av forsommer-meningo-encefalitis-(FSME)-virus-antigen - Google Patents
Matrise med adherent bundede celler, samt fremgangsmåte ved fremstilling av forsommer-meningo-encefalitis-(FSME)-virus-antigen Download PDFInfo
- Publication number
- NO310305B1 NO310305B1 NO19922422A NO922422A NO310305B1 NO 310305 B1 NO310305 B1 NO 310305B1 NO 19922422 A NO19922422 A NO 19922422A NO 922422 A NO922422 A NO 922422A NO 310305 B1 NO310305 B1 NO 310305B1
- Authority
- NO
- Norway
- Prior art keywords
- virus
- cells
- antigen
- matrix
- fsme
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 72
- 239000000427 antigen Substances 0.000 title claims abstract description 54
- 102000036639 antigens Human genes 0.000 title claims abstract description 54
- 108091007433 antigens Proteins 0.000 title claims abstract description 54
- 239000011159 matrix material Substances 0.000 title claims abstract description 27
- 206010014599 encephalitis Diseases 0.000 title claims abstract description 8
- 201000011475 meningoencephalitis Diseases 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 18
- 210000004027 cell Anatomy 0.000 claims abstract description 62
- 241000710771 Tick-borne encephalitis virus Species 0.000 claims abstract description 14
- 239000002609 medium Substances 0.000 claims abstract description 14
- 238000004113 cell culture Methods 0.000 claims abstract description 13
- 210000003501 vero cell Anatomy 0.000 claims abstract description 11
- 230000001419 dependent effect Effects 0.000 claims abstract description 5
- 238000000746 purification Methods 0.000 claims abstract description 5
- 210000004102 animal cell Anatomy 0.000 claims abstract description 4
- 210000005260 human cell Anatomy 0.000 claims abstract description 4
- 230000002779 inactivation Effects 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 230000010412 perfusion Effects 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 241000712891 Arenavirus Species 0.000 claims description 5
- 239000012679 serum free medium Substances 0.000 claims description 5
- 241000710831 Flavivirus Species 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 230000035899 viability Effects 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 abstract description 8
- 239000000758 substrate Substances 0.000 abstract 3
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000002101 lytic effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 210000002308 embryonic cell Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 241000282342 Martes americana Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000012365 batch cultivation Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT2928/89A AT393356B (de) | 1989-12-22 | 1989-12-22 | Verfahren zur herstellung von fsme-virus-antigen |
| PCT/AT1990/000128 WO1991009935A1 (de) | 1989-12-22 | 1990-12-21 | Matrix mit daran adhärent gebundenen zellen, sowie verfahren zur produktion von virus/virusantigen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO922422D0 NO922422D0 (no) | 1992-06-19 |
| NO922422L NO922422L (no) | 1992-08-17 |
| NO310305B1 true NO310305B1 (no) | 2001-06-18 |
Family
ID=3542524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19922422A NO310305B1 (no) | 1989-12-22 | 1992-06-19 | Matrise med adherent bundede celler, samt fremgangsmåte ved fremstilling av forsommer-meningo-encefalitis-(FSME)-virus-antigen |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0506714B1 (fi) |
| JP (1) | JP2633391B2 (fi) |
| AT (2) | AT393356B (fi) |
| CA (1) | CA2071954C (fi) |
| CZ (1) | CZ281804B6 (fi) |
| DE (1) | DE59007659D1 (fi) |
| DK (1) | DK0506714T3 (fi) |
| ES (1) | ES2067916T3 (fi) |
| FI (1) | FI98377C (fi) |
| HR (1) | HRP921354A2 (fi) |
| HU (1) | HU213886B (fi) |
| NO (1) | NO310305B1 (fi) |
| RU (1) | RU2082757C1 (fi) |
| SK (1) | SK659090A3 (fi) |
| WO (1) | WO1991009935A1 (fi) |
| YU (1) | YU242390A (fi) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996015231A2 (en) * | 1994-11-10 | 1996-05-23 | Immuno Aktiengesellschaft | Method for producing biologicals in protein-free culture |
| FR2737412B1 (fr) * | 1995-08-01 | 1997-10-24 | Pasteur Merieux Serums Vacc | Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede |
| EP0841942B2 (fr) * | 1995-08-01 | 2007-12-12 | Sanofi Pasteur | Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu |
| AU743546B2 (en) * | 1998-10-05 | 2002-01-31 | Research Foundation For Microbial Diseases Of Osaka University, The | Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same |
| AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US6951752B2 (en) | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
| US6855535B2 (en) * | 2001-12-10 | 2005-02-15 | Baxter Healthcare S.A. | Method of large scale production of Hepatitis A virus |
| JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
| DK2235197T3 (en) * | 2007-12-27 | 2017-10-09 | Baxalta GmbH | Methods of cell culture |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT358167B (de) * | 1978-12-22 | 1980-08-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen |
| SE445116B (sv) * | 1979-09-12 | 1986-06-02 | Pharmacia Fine Chemicals Ab | Sett att odla celler pa mikroberare med fibronektinytskikt |
| NO161446C (no) * | 1981-03-13 | 1989-08-16 | Damon Biotech Inc | Fremgangsmaate for dyrking av celler som er avhengige av forankring. |
| SE8103138L (sv) * | 1981-05-19 | 1982-11-20 | Pharmacia Fine Chemicals Ab | Mikroberare for odling av forankringsberoende celler |
| CA1206900A (en) * | 1981-12-21 | 1986-07-02 | Raymond L. Downs | Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture |
| AT385203B (de) * | 1985-04-26 | 1988-03-10 | Immuno Ag | Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine |
| DD274336A3 (de) * | 1985-10-03 | 1989-12-20 | Npo Biolar | Verfahren zur Gewinnung einer Mikroträgersubstanz für die Zellkultivierung |
-
1989
- 1989-12-22 AT AT2928/89A patent/AT393356B/de not_active IP Right Cessation
-
1990
- 1990-12-21 DE DE59007659T patent/DE59007659D1/de not_active Expired - Fee Related
- 1990-12-21 JP JP50113291A patent/JP2633391B2/ja not_active Expired - Fee Related
- 1990-12-21 CZ CS906590A patent/CZ281804B6/cs not_active IP Right Cessation
- 1990-12-21 ES ES91900666T patent/ES2067916T3/es not_active Expired - Lifetime
- 1990-12-21 YU YU242390A patent/YU242390A/sh unknown
- 1990-12-21 CA CA 2071954 patent/CA2071954C/en not_active Expired - Lifetime
- 1990-12-21 RU SU905052769A patent/RU2082757C1/ru not_active IP Right Cessation
- 1990-12-21 EP EP19910900666 patent/EP0506714B1/de not_active Expired - Lifetime
- 1990-12-21 AT AT91900666T patent/ATE113652T1/de not_active IP Right Cessation
- 1990-12-21 SK SK6590-90A patent/SK659090A3/sk not_active IP Right Cessation
- 1990-12-21 WO PCT/AT1990/000128 patent/WO1991009935A1/de active IP Right Grant
- 1990-12-21 DK DK91900666T patent/DK0506714T3/da not_active Application Discontinuation
- 1990-12-21 HU HU9202009A patent/HU213886B/hu unknown
-
1992
- 1992-06-18 FI FI922851A patent/FI98377C/fi active
- 1992-06-19 NO NO19922422A patent/NO310305B1/no not_active IP Right Cessation
- 1992-11-25 HR HRP921354 patent/HRP921354A2/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE59007659D1 (de) | 1994-12-08 |
| EP0506714A1 (de) | 1992-10-07 |
| AT393356B (de) | 1991-10-10 |
| HU9202009D0 (en) | 1992-10-28 |
| SK279236B6 (sk) | 1998-08-05 |
| WO1991009935A1 (de) | 1991-07-11 |
| HUT65410A (en) | 1994-06-28 |
| CZ281804B6 (cs) | 1997-02-12 |
| EP0506714B1 (de) | 1994-11-02 |
| FI98377C (fi) | 1997-06-10 |
| RU2082757C1 (ru) | 1997-06-27 |
| ATA292889A (de) | 1991-03-15 |
| NO922422D0 (no) | 1992-06-19 |
| FI922851A0 (fi) | 1992-06-18 |
| HRP921354A2 (en) | 1996-02-29 |
| SK659090A3 (en) | 1998-08-05 |
| CA2071954C (en) | 1996-06-18 |
| NO922422L (no) | 1992-08-17 |
| FI98377B (fi) | 1997-02-28 |
| JPH05502581A (ja) | 1993-05-13 |
| ATE113652T1 (de) | 1994-11-15 |
| CZ659090A3 (en) | 1996-11-13 |
| CA2071954A1 (en) | 1991-06-23 |
| HU213886B (en) | 1997-11-28 |
| FI922851A (fi) | 1992-06-18 |
| JP2633391B2 (ja) | 1997-07-23 |
| ES2067916T3 (es) | 1995-04-01 |
| YU242390A (sh) | 1993-05-28 |
| DK0506714T3 (da) | 1995-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002338666B2 (en) | Multiplication of viruses in a cell culture | |
| Van Hemert et al. | Homogeneous cultivation of animal cells for the production of virus and virus products | |
| US3520972A (en) | Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains | |
| NO310305B1 (no) | Matrise med adherent bundede celler, samt fremgangsmåte ved fremstilling av forsommer-meningo-encefalitis-(FSME)-virus-antigen | |
| AU2007305595C1 (en) | IPV-DPT vaccine | |
| US3935066A (en) | Cell lines | |
| US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
| US3585266A (en) | Live rabies virus vaccine and method for the production thereof | |
| Elliott | Nonperfused attachment systems for cell cultivation | |
| IE47060B1 (en) | Process for the cultivation of viruses | |
| JPH0998778A (ja) | マレク病ワクチン | |
| US4021302A (en) | Cell cultures | |
| Moran | A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine | |
| US3228840A (en) | Virus culture | |
| Dunham et al. | Propagation of poliovirus in chick embryo cell cultures. I. Cultivation of 3 virus types | |
| Nicholson | Growth of fish cell lines on microcarriers | |
| NO860180L (fi) | ||
| Choi et al. | Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle | |
| US20110020909A1 (en) | Methods Of Culturing Lawsonia Intracellularis | |
| Mifune et al. | Susceptibility of various cell lines to rabies virus | |
| RU2816765C1 (ru) | Способ получения культуральной инактивированной вакцины против вируса бешенства | |
| Hayle | Culture of respiratory syncytial virus infected diploid bovine nasal mucosa cells on cytodex 3 microcarriers | |
| CN101525597A (zh) | 新的甲型肝炎灭活疫苗病毒毒株及其培养方法 | |
| SU1317021A1 (ru) | Штамм диплоидных клеток кожи и мышц эмбриона человека,используемый дл культивировани вирусов | |
| RU2140451C1 (ru) | Штамм культивируемых клеток почки suis domestica l. для культивирования вирусов животных |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |